PKIA
cAMP-dependent protein kinase inhibitor alpha
Also known as: IPKA_HUMAN, PRKACN1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P61925
- Gene
- PKIA
- Ensembl
- ENSG00000171033
- Chromosome
- 8
- Canonical length
- 76 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene is a member of the cAMP-dependent protein kinase (PKA) inhibitor family. This protein was demonstrated to interact with and inhibit the activities of both C alpha and C beta catalytic subunits of the PKA. Alternatively spliced transcript variants encoding the same protein have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
76 residues, UniProt reviewed canonical sequence.
>P61925|PKIA
1 MTDVETTYAD FIASGRTGRR NAIHDILVSS ASGNSNELAL KLAGLDINKT EGEEDAQRSS
61 TEQSGEAQGE AAKSESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PKIA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 1,088 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 1,088 nTPM
- tongue: 890 nTPM
- heart muscle: 174 nTPM
- parathyroid gland: 102 nTPM
- basal ganglia: 63 nTPM
- cerebral cortex: 61 nTPM
Single-cell type
- myonuclei: 269 nCPM
- lactotrophs: 203 nCPM
- somatotrophs: 189 nCPM
- brain inhibitory neurons: 175 nCPM
- retinal amacrine cells: 165 nCPM
- thymic myoid cells: 158 nCPM
Immune cell
- T-reg: 22 nTPM
- memory CD4 T-cell: 9.2 nTPM
- naive CD4 T-cell: 7.7 nTPM
- naive CD8 T-cell: 4.6 nTPM
- total PBMC: 2.5 nTPM
- memory B-cell: 2.3 nTPM
Brain region
- cerebral cortex: 84 nTPM
- basal ganglia: 83 nTPM
- hypothalamus: 81 nTPM
- hippocampal formation: 72 nTPM
- cerebellum: 67 nTPM
- amygdala: 60 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0.14
- gnomAD missense Z
- 0.79
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cAMP/PKA signal transduction
- negative regulation of protein import into nucleus
- negative regulation of transcription by RNA polymerase II
- regulation of G2/M transition of mitotic cell cycle
- negative regulation of cAMP-dependent protein kinase activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PKIA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PKIA as an antibody target. Whether an autoantibody or antibody against PKIA could matter depends on whether native PKIA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PKIA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PKIA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...